| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Molecular Biology (T.-Z.S., M.W.) and Cell Biology (D.L.O., A.R.S.), Parke-Davis Pharmaceutical Research Division of Warner Lambert Co., Ann Arbor, Michigan 48105
Address all correspondence and requests for reprints to: Dr. Ti-Zhi Su, Department of Molecular Biology, Parke-Davis Pharmaceutical Research Division of Warner Lambert Co., 2800 Plymouth Road, Ann Arbor, Michigan 48105. E-mail: sut{at}aa.wl.com
System A is one of the most highly regulated transport systems for
transport of neutral amino acids into mammalian cells. Stimulation of
uptake of
-[3H]methylaminoisobutyric acid (MeAIB), a
nonmetabolizable system A substrate, by a novel insulin-sensitizing
agent, troglitazone, in 3T3-L1 adipocytes was investigated. Treating
adipocytes with troglitazone alone resulted in a time- and
dose-dependent increase in the uptake of MeAIB. The peak stimulation
appeared about 24 h after troglitazone addition. Both
troglitazone- and insulin-stimulated transport activities increased
markedly after the induction of differentiation of preadipocytes into
adipocytes, and declined to a steady state level in adipocytes. The
stimulated MeAIB uptake exhibited substrate specificity typical of
system A and was mediated by a single component as determined by
Eadie-Hofstee plots. The stimulation by troglitazone and that by
insulin were similarly sensitive to actinomycin D and cycloheximide,
suggesting that both agents may induce de novo synthesis
of the same type of system A transport. Apart from the
insulin-independent effect, troglitazone also showed an
insulin-dependent action characterized by enhanced sensitivity to
insulin. The synergistic stimulation of MeAIB uptake by
coadministration of insulin and troglitazone was most prominent at the
early stages of adipocyte differentiation. Pretreating cells with
troglitazone during the differentiation attenuated the sensitivity of
insulin to inhibition by actinomycin D, suggesting that troglitazone
may enhance the insulin action by stabilizing messenger RNA involved in
system A function.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |